Is Reticular Macular Disease a Choriocapillaris Perfusion Problem?

The etiology of reticular macular disease (RMD), a sub-phenotype of age-related macular degeneration (AMD), is controversial and has not been clarified. RMD is suspected to be a multifactorial, complex disease with genetic, environmental, and systemic factors playing an important role in its origin. Findings from combinations of different imaging modalities suggest that the pattern that characterizes this condition is associated with an alteration of the choriocapillaris blood flow. If the choroid is indeed affected in RMD, the possible linkage with inflammatory or other systemic diseases could be better supported

Is Reticular Macular Disease a Choriocapillaris Perfusion Problem?

The etiology of reticular macular disease (RMD), a sub-phenotype of age-related macular degeneration (AMD), is controversial and has not been clarified. RMD is suspected to be a multifactorial, complex disease with genetic, environmental, and systemic factors playing an important role in its origin. Findings from combinations of different imaging modalities suggest that the pattern that characterizes this condition is associated with an alteration of the choriocapillaris blood flow. If the choroid is indeed affected in RMD, the possible linkage with inflammatory or other systemic diseases could be better supported

Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial.

PURPOSE:To evaluate the dynamic remodeling of drusen in subjects with unilateral neovascular age-related macular degeneration (AMD) receiving a three-year course of oral docosahexaenoic acid (DHA) or placebo. SETTING:Institutional setting. METHODS:Three hundred subjects with age-related maculopathy and neovascular AMD in the fellow eye were randomly assigned to receive either 840 mg/day DHA or placebo for 3 years. Main outcome measures of this post-hoc sub-group analysis were progression of drusen number, total diameter, and total area on fundus photography, and their association with DHA supplementation, socio-demographic and genetic characteristics. RESULTS:Drusen progression was analyzed in 167 subjects that did not develop CNV (87 that received DHA and 80 that received placebo). None of the drusen remodeling outcomes were significantly associated with DHA supplementation. Total drusen diameter reduction in the inner subfield was significantly associated with age (older patients: r = -0.17; p = 0.003). Women showed a tendency to decreased total drusen diameter in the inner subfield with CFH polymorphism (p = 0.03), where women with TT genotype tended to have a greater reduction in drusen diameter than other genotypes (CC and CT). Drusen area in the inner subfield was more reduced in older patients (r = -0.17) and in women (p = 0.01). Drusen number showed no significant trends. CONCLUSIONS:Dynamic drusen remodeling with net reduction in drusen load over three years was found in patients with exudative AMD in one eye and drusen in the other eye (study-eye). This reduction was correlated with increased age and female gender, and showed a tendency to be influenced by CFH genotype, but did not appear to be affected by DHA supplementation. TRIAL REGISTRATION:Controlled-Trials.com ISRCTN98246501

Associations of 3-year drusen number, diameter and area remodeling with socio-demographic and genetics characteristics at baseline.

<p>Associations of 3-year drusen number, diameter and area remodeling with socio-demographic and genetics characteristics at baseline.</p

Segmentation of reticular pseudodrusen.

<p>A) original fundus photograph with large area containing both reticular macular disease (reticular pseudodrusen) and ordinary soft drusen outlined in black. The soft drusen are confined to the central macula. The reticular pseudodrusen extend to the arcades. B) original color fundus photo C) both reticular pseudodrusen and soft drusen are segmented (green) on the color photo within the area identified in A and within the superimposed Wisconsin grading template. D) The area of reticular macular disease is separately enclosed in red, and was excluded from drusen measurements.</p

Socio-demographic, genetics and drusen characteristics at baseline.

<p>Socio-demographic, genetics and drusen characteristics at baseline.</p

Comparison of drusen characteristics between baseline and 3 years according to treatment group.

<p>Comparison of drusen characteristics between baseline and 3 years according to treatment group.</p

Drusen regression and its correlation with new geographic atrophy (GA).

<p><b>A:</b> Color photo, right eye, Visit 1 (V1). <b>B:</b> V1 photo with soft drusen segmented in green, total pixel area 2,452. GA is not present. <b>C:</b> Color photo, right eye, Visit 5 (V5), showing new GA, <b>D:</b> V5 photo with GAs segmented in blue, total pixel area 4,161. Drusen from V1 that were absorbed in the GA are overlaid and segmented in red, total pixel area 381, or 9% of geographic atrophy total area. Compared to the original drusen area present in V1 of 2,452 pixels, the 381 drusen pixels converting to GA in V5 represent 16% of the original drusen area.</p

Associations of DHA supplementation with drusen remodeling.

<p>Associations of DHA supplementation with drusen remodeling.</p